View in EDS

HARMONIZE Asia: A Phase III Randomized Study to Investigate the Efficacy and Safety of Sodium Zirconium Cyclosilicate in Patients with Hyperkalemia in China.

Saved in:
Bibliographic Details
Title: HARMONIZE Asia: A Phase III Randomized Study to Investigate the Efficacy and Safety of Sodium Zirconium Cyclosilicate in Patients with Hyperkalemia in China.
Authors: Liang X; Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China., Lu W; The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Yu X; Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address: yuxueqing@gdph.org.cn., Cheng H; Anzhen Hospital, Capital University of Medical Science, Beijing, China., He Q; Sichuan Provincial People's Hospital, Chengdu, China., Peng Q; Zhuzhou Central Hospital, Zhuzhou, China., Ni Z; Department of Nephrology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Long G; Tianjin People's Hospital, Tianjin, China., Wang L; The Second Hospital of Shanxi Medical University, Taiyuan, China., Chen W; The First Affiliated Hospital Of Sun Yat-Sen University, Guangdong, China., Li R; The Second Hospital of Tianjin Medical University, Tianjin, China., Zhao J; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Zhang Y; AstraZeneca R&D, Shanghai, China., Lisovskaja V; Department of Biostatistics, Research and Development, AstraZeneca, Gothenburg, Sweden., Tang Z; AstraZeneca R&D, Shanghai, China.
Source: Clinical therapeutics [Clin Ther] 2024 Sep; Vol. 46 (9), pp. 702-710. Date of Electronic Publication: 2024 Aug 06.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39112102
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: HARMONIZE Asia: A Phase III Randomized Study to Investigate the Efficacy and Safety of Sodium Zirconium Cyclosilicate in Patients with Hyperkalemia in China.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Liang+X%22">Liang X</searchLink>; Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Lu+W%22">Lu W</searchLink>; The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.<br /><searchLink fieldCode="AU" term="%22Yu+X%22">Yu X</searchLink>; Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address: yuxueqing@gdph.org.cn.<br /><searchLink fieldCode="AU" term="%22Cheng+H%22">Cheng H</searchLink>; Anzhen Hospital, Capital University of Medical Science, Beijing, China.<br /><searchLink fieldCode="AU" term="%22He+Q%22">He Q</searchLink>; Sichuan Provincial People's Hospital, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Peng+Q%22">Peng Q</searchLink>; Zhuzhou Central Hospital, Zhuzhou, China.<br /><searchLink fieldCode="AU" term="%22Ni+Z%22">Ni Z</searchLink>; Department of Nephrology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Long+G%22">Long G</searchLink>; Tianjin People's Hospital, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; The Second Hospital of Shanxi Medical University, Taiyuan, China.<br /><searchLink fieldCode="AU" term="%22Chen+W%22">Chen W</searchLink>; The First Affiliated Hospital Of Sun Yat-Sen University, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Li+R%22">Li R</searchLink>; The Second Hospital of Tianjin Medical University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhao+J%22">Zhao J</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; AstraZeneca R&D, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Lisovskaja+V%22">Lisovskaja V</searchLink>; Department of Biostatistics, Research and Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Tang+Z%22">Tang Z</searchLink>; AstraZeneca R&D, Shanghai, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227706726%22">Clinical therapeutics</searchLink> [Clin Ther] 2024 Sep; Vol. 46 (9), pp. 702-710. <i>Date of Electronic Publication: </i>2024 Aug 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Excerpta+Medica%22">Excerpta Medica </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7706726 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-114X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201492918%22">01492918 </searchLink><i>NLM ISO Abbreviation: </i>Clin Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39112102
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clinthera.2024.07.004
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 702
    Titles:
      – TitleFull: HARMONIZE Asia: A Phase III Randomized Study to Investigate the Efficacy and Safety of Sodium Zirconium Cyclosilicate in Patients with Hyperkalemia in China.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liang X
      – PersonEntity:
          Name:
            NameFull: Lu W
      – PersonEntity:
          Name:
            NameFull: Yu X
      – PersonEntity:
          Name:
            NameFull: Cheng H
      – PersonEntity:
          Name:
            NameFull: He Q
      – PersonEntity:
          Name:
            NameFull: Peng Q
      – PersonEntity:
          Name:
            NameFull: Ni Z
      – PersonEntity:
          Name:
            NameFull: Long G
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Chen W
      – PersonEntity:
          Name:
            NameFull: Li R
      – PersonEntity:
          Name:
            NameFull: Zhao J
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Lisovskaja V
      – PersonEntity:
          Name:
            NameFull: Tang Z
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1879-114X
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Clinical therapeutics
              Type: main
ResultId 1